Healthcare and Life Science
Fuse Diagnostics raises £1 million to scale rapid point-of-need molecular testing platform
Financing will accelerate commercialisation of Fuse Diagnostics’ proprietary Flip platform, expanding its portfolio of rapid, laboratory-quality molecular diagnostics for high-value industrial and life science applicationsInvestment led by The FSE Group alongside existing and new angel ...
Blood markers linked to specific types of stroke identified by Cambridge researchers
Researchers at the University of Cambridge have identified two key chemical markers in the blood that are directly linked to different types of stroke caused by small vessel disease in the brain. The discovery could pave the way for earlier diagnosis, better disease tracking, and more t...
Charity seeks half-marathon runners for March 27
Charity seeks people who like a challenge to join their Cambridge Half Marathon Team on 14th March 2027 ...
East Anglian Air Ambulance supporters take on Trek 24 in Cambridge
The first-ever Trek 24 Cambridgeshire took place on Sunday 6 September, raising vital funds to support East Anglian Air Ambulance and help secure the future of its lifesaving service across the region – with 150 people taking part in the event. ...
After the funding round: how to build the foundations for sustainable growth
Securing investment is a significant milestone for any business.For an early-stage life sciences company, it may mean moving from scientific validation towards commercialisation. For a technology business, it might create the opportunity to accelerate customer acquisition or enter new m...
Dragon Boat teams smash fundraising target with £50,000+ raised for new Cambridge Cancer Research Hospital
This year's Cambridge Dragon Boat Festival saw a day of firsts, a day of celebrations and a day of coming together to remember why everyone involved was taking part.At what marked the festival's 20th year, the 43 teams that took part smashed the £50,000 target, currently £52,500 and ris...
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy programme for epilepsy ahead of first-in-human trial
Collaboration with AAV-specialist CDMO will support scalable production of EPY201 for focal refractory epilepsy affecting 10 million people ...
Yourgene Health Insight DPYD Assay Achieves IVDR Accreditation
Comprehensive pharmacogenetic testing solution aligned with latest clinical guidance to support informed chemotherapy treatment decisions. ...
Eppendorf launches new refrigerated Centrifuge 5811 R
Hamburg, Germany, 8 September, 2026 – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today announced the launch of the Centrifuge 5811 R, a re...
OutSee awarded Innovate UK grant for agentic AI pilot study to enhance drug target validation
Pilot study to develop prototype agentic AI sub-system for initial validation screening of targets identified using AI predictive genomics platform, NomalyFunding provided jointly by Innovate UK and Empirical Ventures through Innovate UK Growth Catalyst – Investor Partnership grant prog...